Newsroom

Serac Imaging Systems Limited, the medtech company developing ‘Seracam®’ a portable hybrid gamma-optical camera for medical imaging, and its clinical investigators from The Ohio State University Wexner Medical Center, U.S., and the Faculty of Medicine at the University of Malaya, Malaysia, announce that posters featuring clinical trials directed using Seracam® are being presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting taking place from 21-24 June, 2025 in New Orleans, U.S.

Serac Life Sciences, the parent company of molecular imaging businesses Serac Imaging Systems Ltd and Serac Healthcare Ltd,  announce that their Scientific Advisor, Professor Alan Perkins, has been awarded a Member of the Order of the British Empire (MBE) in the King’s Birthday Honours in recognition of his outstanding services to patient care and clinical science.

The story of Seracam’s development from technology designed for outer space to the civil nuclear industry features in the April 2025 edition of Nuclear Engineering International.

Serac Imaging Systems Limited  announces that abstracts submitted by its clinical partners at the University of Malaya Medical Centre in Malaysia and The Ohio State University, USA, have been accepted for presentation at the prestigious Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting taking place from 21-24 June in New Orleans, USA.

Serac Imaging Systems Limited announces that its clinical partners from the University Malaya Medical Centre and Taylor’s University, Malaysia have presented the first clinical results using Seracam® for small organ imaging at the European Association of Nuclear Medicine (EANM) Congress 2024 in Hamburg, Germany. The study involves a comparison of the diagnostic accuracy and  resolution of radiopharmaceutical uptake between Seracam® and  standard gamma cameras, using images obtained from the same patient on the same day.

Serac Imaging Systems’ clinical partner, the University of Malaya Medical Centre, has today presented initial findings and images acquired using Seracam® for image guided surgery in a sentinel lymph node biopsy procedure at the International Conference on Hybrid Imaging (IPET 2024) organised by the International Atomic Energy Agency (IAEA). Based on this first user case, the investigators have determined that Seracam® demonstrates clinical feasibility for sentinel lymph node imaging in breast cancer management.